Answers are grounded in this paper and cite their sources.
Non-alcoholic fatty liver disease (NAFLD) has become the most common type of chronic liver disorder, which with risk of progression to cirrhosis and cancer. Due to the lack of definitive symptoms, liver biopsy is still the gold standard in the diagnosis of NAFLD. However, over the past few decades, there have been significant advancements in non-invasive biomarkers and techniques for diagnosing NAFLD. The analysis of volatile organic compounds (VOCs) in exhaled breath is becoming one of the promising strategies for NAFLD detection as it may offer an inexpensive, rapid, and non-invasive diagnostic method. In this article,we provide a comprehensive review of the current and emerging VOCs in exhaled breath used for assessing NAFLD, highlighting their diagnostic specificity across different stages of the disease. This article reviews the application of isoprene, acetone, ethanol, dimethyl sulfide, carbon disulphide, acetaldehyde, methanol, trimethylamine, styrene, D-limonene, acetophenone, terpinene, pentane, methane, and others in the analysis of exhaled breath for NAFLD. The study shows that exhaled breath analysis has a certain value in the diagnosis of NAFLD. We believe that the role of exhaled breath analysis in the diagnosis of NAFLD may be a key area for future research. However, due to the limitations of the current studies, the practical application of exhaled breath analysis in NAFLD diagnosis remains a developing field with much progress yet to be made.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: